Stocklytics Platform
Asset logo for symbol ASMB
Assembly Biosciences
ASMB63
$13.52arrow_drop_down0.29%-$0.04
Asset logo for symbol ASMB
ASMB63

$13.52

arrow_drop_down0.29%

Income Statement (ASMB)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$10.95M-$12.20M-$10.72M-$12.55M-$15.16M
EBITDA-$10.92M-$12.17M-$10.69M-$12.46M-$15.04M
gross Profit$6.84M$8.50M$5.75M$7.07M-$116.00K
NET Income-$9.61M-$11.15M-$9.07M-$10.96M-$14.42M
total Revenue$6.84M$8.53M$5.78M$7.16M$0.00

Balance Sheet (ASMB)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$27.01M-$17.46M-$16.81M-$17.49M-$25.73M
stockholders Equity$26.00M$34.68M$32.60M$41.09M$41.71M
total Assets$100.26M$115.32M$119.88M$137.46M$51.62M
total Debt$1.44M$1.74M$1.93M$2.34M$919.00K
total Liabilities$74.25M$80.64M$87.28M$96.37M$9.91M

Cash Flow (ASMB)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$0.00$12.45M$0.00$9.19M$0.00
free Cash Flow-$15.24M-$17.11M-$18.37M$73.57M-$13.98M
investing Cash Flow-----
operating Cash Flow-$15.24M-$17.10M-$18.36M$73.64M-$13.84M

Assembly Biosciences (ASMB) Financials

The income statement for Assembly Biosciences Inc (ASMB) provides a comprehensive overview of the company's financial performance. It shows the revenue generated by the company during a specific period and deducts all the expenses incurred to arrive at the net income. The income statement includes various components such as gross profit, operating profit (EBIT), and net income from stockholders. Assembly Biosciences Inc has been consistently improving its financial position, as evident from its robust total revenue growth. The company has been able to achieve this growth by focusing on key areas like research and development, strategic partnerships, and the commercialization of its innovative products.
The balance sheet of Assembly Biosciences Inc (ASMB) reflects the company's financial position at a specific point in time. It provides a snapshot of its assets, liabilities, and shareholders' equity. The balance sheet is divided into two main sections: current assets and non-current assets. Assembly Biosciences Inc has a healthy balance sheet, with a strong cash position and no net debt. The company has been able to fund its operations and invest in future growth opportunities through its positive cash flow. Assembly Biosciences Inc's strong financial position and solid cash flow generation provide a strong foundation for its future growth and profitability.
add Assembly Biosciences  to watchlist

Keep an eye on Assembly Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level